Streetbeat News

Analyst Ratings

GB

Deutsche Bank analyst Nate Svensson has initiated coverage on Global Blue Gr Holding (NYSE:GB) with a Buy rating and a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 9:48 am

ENPH

Truist Securities analyst Jordan Levy has downgraded Enphase Energy (NASDAQ:ENPH) from Buy to Hold and lowered the price target from $210 to $135.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 9:47 am

RTX

RBC Capital analyst Ken Herbert has downgraded RTX (NYSE:RTX) from Outperform to Sector Perform and lowered the price target from $105 to $82.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 9:46 am

PERI

Raymond James analyst Andrew Marok has downgraded Perion Network (NASDAQ:PERI) from Outperform to Market Perform.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 9:45 am

RTX

Barclays analyst David Strauss has downgraded RTX (NYSE:RTX) from Overweight to Equal-Weight and lowered the price target from $100 to $75.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 9:44 am

IAG

RBC Capital analyst Josh Wolfson has upgraded Iamgold (NYSE:IAG) from Underperform to Sector Perform and raised the price target from $1.75 to $2.75.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 9:43 am

CVS

Wolfe Research analyst Justin Lake has upgraded CVS Health (NYSE:CVS) from Peer Perform to Outperform and set a price target of $80.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 9:42 am

DOGEUSD

TWTR

Elon Musk's new biography reveals his skepticism about using blockchain technology for Twitter, despite his interest in cryptocurrencies like Dogecoin. The book also discusses Sam Bankman-Fried, former CEO of FTX, and his enthusiasm for incorporating blockchain into Twitter. Musk's primary banker at Morgan Stanley, Michael Grimes, tried to facilitate a meeting between Musk and Bankman-Fried, who was willing to contribute $5 billion to the potential acquisition of Twitter.

Portfolio Pulse from Mehab Qureshi

September 12, 2023 | 9:39 am

GERN

Goldman Sachs analyst Corinne Jenkins has upgraded Geron (NASDAQ:GERN) from Neutral to Buy and announced a $4 price target.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 9:28 am

BCYC

Needham analyst Ami Fadia has reiterated a 'Buy' rating on Bicycle Therapeutics (NASDAQ:BCYC) and maintained a price target of $46.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 9:25 am